Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification for increased metabolic stability. It is studied for its ability to stimulate GH and IGF-1 release via GHRH receptor activation, with preclinical research supporting targeted visceral adipose tissue reduction and metabolic health applications.
Tesamorelin
SKU: 39
$110.00Price
- Full-length GHRH(1-44) analogue with enhanced metabolic stability via trans-3-hexenoic acid modification
- Specifically studied for visceral adipose tissue (VAT) reduction in preclinical metabolic research
- Increases GH and IGF-1 levels through physiological GHRH receptor stimulation
- Investigated for metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and body composition research
- Preserves lean body mass while supporting fat oxidation in preclinical models
